Vizimpro® (dacomitinib)
for Lung Cancer

Vizimpro (dacomitinib) is a prescription medicine used to treat metastatic non-small cell lung cancer (NSCLC) with specific EGFR gene mutations, such as exon 19 deletion or exon 21 L858R substitution. It works by slowing or stopping the growth of cancer cells.

Heart